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Background: Antibiotic prescribing in dentistry accounts for 9% of total antibiotic prescriptions in Scottish primary
care. The Scottish Dental Clinical Effectiveness Programme (SDCEP) published guidance in April 2008 (2nd edition,
August 2011) for Drug Prescribing in Dentistry, which aims to assist dentists to make evidence-based antibiotic
prescribing decisions. However, wide variation in prescribing persists and the overall use of antibiotics is increasing.
Methods: RAPiD is a 12-month partial factorial cluster randomised trial conducted in NHS General Dental Practices
across Scotland. Its aim is to compare the effectiveness of individualised audit and feedback (A&F) strategies for
the translation into practice of SDCEP recommendations on antibiotic prescribing. The trial uses routinely collected
electronic healthcare data in five aspects of its design in order to: identify the study population; apply eligibility criteria;
carry out stratified randomisation; generate the trial intervention; analyse trial outcomes.
Eligibility was determined on contract status and a minimum level of recent NHS treatment provision. All eligible
dental practices in Scotland were simultaneously randomised at baseline either to current audit practice or to an
intervention group. Randomisation was stratified by single-handed/multi-handed practices. General dental practitioners
(GDPs) working at intervention practices will receive individualised graphical representations of their antibiotic
prescribing rate from the previous 14 months at baseline and an update at six months. GDPs could not be
blinded to their practice allocation. Intervention practices were further randomised using a factorial design to receive
feedback with or without: a health board comparator; a supplementary text-based intervention; additional feedback at
nine months. The primary outcome is the total antibiotic prescribing rate per 100 courses of treatment over the year
following delivery of the baseline intervention.
A concurrent qualitative process evaluation will apply theory-based approaches using the Consolidated Framework for
Implementation Research to explore the acceptability of the interventions and the Theoretical Domains Framework to
identify barriers and enablers to evidence-based antibiotic prescribing behaviour by GDPs.
Discussion: RAPiD will provide a robust evaluation of A&F in dentistry in Scotland. It also demonstrates that linked
administrative datasets have the potential to be used efficiently and effectively across all stages of an randomised
controlled trial.
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The Scottish Dental Clinical Effectiveness Programme
(SDCEP) was established in 2004 as a joint initiative of
the National Dental Advisory Committee and NHS Edu-
cation for Scotland (NES) with the aim of providing
user-friendly evidence-based guidance in priority areas
for dental healthcare in Scotland. The guidance it pro-
duces is designed to assist dental teams and to improve
patient health by presenting advice and recommenda-
tions that are based on the best available information,
thereby facilitating the translation of research evidence
into practice and assisting in compliance to the ever
changing regulatory framework of healthcare provision.
In April 2008, SDCEP published guidance for Drug
Prescribing in Dentistry that is suitable for informing
dental practitioners in the primary care sector, and ap-
plies to all patients who would be treated in the primary
care sector in Scotland [1]. The guidance brought to-
gether advice and recommendations on dental prescrib-
ing from the British National Formulary (BNF) and the
BNF for Children and from the National Institute for
Health and Clinical Excellence and presented it in a
readily accessible, problem orientated style. In August
2011, a second edition of Drug Prescribing for Dentistry
was published by SDCEP. In addition, a ‘dental prescrib-
ing’ app for iPhone®, iPad®, and iPod touch® was
launched in April 2012 [2].
Despite the introduction of the SDCEP guidance, there
is wide variation in dental drug prescribing in Scotland.
Antibiotic prescribing in dentistry accounts for 9% of
total antibiotic prescribing in primary care in Scotland.
In 2011, the overall use of antibiotics in dentistry was re-
ported to be 7.6% higher than in 2010 [3]. General den-
tal practitioners (GDPs) prescribe antibiotics regularly
for the management of dental infections, but treatment
is often guided by personal experience and knowledge
[4,5], and in many cases antibiotics are prescribed in-
appropriately to patients with dental emergencies [6]. It
is widely recognised that antimicrobial resistance is a
major threat to public health and patient safety. Inappro-
priate antibiotic prescribing contributes to an increasing
risk of antimicrobial resistance [3].
In dentistry, there is ample evidence that the imple-
mentation of guidance by dental professionals is variable
and understanding how to change this is limited [7].
However, there is a lack of robust, generalisable evidence
on how best to promote the translation of guidance into
practice. This was highlighted in the Health Technology
Assessment (HTA) systematic review of the effectiveness
and efficiency of guideline dissemination and implemen-
tation strategies [8], which found evidence that although
dissemination and implementation of guidance could lead
to compliance with recommendations, the effect varied
both within and across interventions.Audit and Feedback (A&F) is defined as ‘any summary
of clinical performance of healthcare over a specified
period of time’ aimed at changing health professional be-
haviour [9]. A&F is a commonly used approach and has
consistently demonstrated small to moderate sized effects,
[9] though predicting the clinical circumstances where ef-
fects will be moderate and those where effects are small
has been elusive [10].
In Scotland, routinely collected electronic healthcare
data (e.g., number of claims for treatment and number
of prescription items dispensed) are available at the level
of the individual GDP. One way in which current practice
may be enhanced is by the provision of individualised
feedback on antibiotic prescribing to GDPs. Another way
is with the addition of behaviour change techniques
(BCTs). A BCT is a ‘systematic procedure included as an
active component of an intervention designed to change
behaviour’ [11]. BCTs are the ‘active ingredients’ in an
intervention (i.e., they are the proposed mechanisms of
change). Guidelines tend to be lengthy, and it is un-
known whether providing clinicians with a distillation
of the guidelines solely into the BCTs could be an ad-
vantageous way of enhancing implementation and
changing behaviour.
The RAPiD (Reducing Antibiotic Prescribing in
Dentistry) trial will compare the effectiveness of indivi-
dualised A&F strategies for the translation into practice of
SDCEP recommendations on antibiotic prescribing. The
objectives of the trial relate to antibiotic prescribing
behaviour at dental practice level. The research question
being addressed is: In comparison to current practice,
does the provision of individualised feedback on antibiotic
prescribing at differing intervals (i.e., 0 and 6 months ±
9 months), with or without a comparator, with or without
a text-based intervention reiterating the ‘active ingredi-
ents’ within the SDCEP recommendations on antibiotic
prescribing lead to a reduction in antibiotic prescribing in
dental primary care in Scotland?
In addition, a process evaluation will explore the accept-
ability of the individualised A&F strategies and identify
barriers and enablers to evidence-based antibiotic pre-
scribing practice in dentistry. The RAPiD trial is being
conducted as part of NES’s TRiaDS (Translation Research
in a Dental Setting) programme [12]. At writing (December
2013), data collection and delivery of the individualised
baseline and six months A&F interventions have taken
place.
Methods
Trial Design
The RAPiD trial is a 12-month partial factorial cluster
randomised controlled trial conducted in NHS General
Dental Practices across Scotland. A cluster design was
used to reduce contamination within dental practices. A
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A&F strategies (i.e., inclusion of a comparator, inclusion
of a text-based intervention and the interval between re-
ceiving feedback). We will also explore the effects of the
interventions combined. A control group was included
to test the effectiveness of any form of A&F strategy
(Figure 1).
The trial uses routinely collected electronic healthcare
data in five aspects of the trial design in order to: identify
the study population; apply eligibility criteria; carry out
stratified randomisation; generate individualised feedback
for the trial intervention; and analyse trial outcomes.
Permission was granted by the NHS National Services
Scotland (NSS) Privacy Advisory Committee (PAC Ref:
10/12) to link data from the Management and Dental
Accounting System (MIDAS) database with the Prescribing
Information System for Scotland (PRISMS) database.
Initial data linkage and processing
Information Services Division (ISD) of NHS National
Services Scotland (NSS) holds the MIDAS and PRISMS
databases. The MIDAS database contains claims informa-
tion relating to all courses of NHS dental treatment pro-
vided by GDPs in the General Dental Service since 1990.
The PRISMS database contains information for all pri-
mary care prescriptions dispensed in community pharma-
cies (including dental prescriptions) since April 2004.
ISD supplied the TRiaDS Programme Office with the
treatment data extracted from MIDAS and with monthly
dental prescribing PRISMS data. The data from MIDAS
and PRISMS were linked to a further extract from
MIDAS containing contact information for GDPs and
dental practices across Scotland. This extract was sup-
plied by the Practitioner Services Division (PSD) of NHS
NSS and listed all GDPs practising as at April 2013.Figure 1 Study design.The GDP list number was used as the single common
identifier. The list number is common to both MIDAS
and PRISMS (in PRISMS the list number is used as the
Prescriber ID) and is a unique number issued to GDPs
by Health Boards in order for them to submit item-of-
service and registration claims for payment. The linked
dataset does not contain any patient identifiable infor-
mation and was processed in accordance with the Data
Protection Act 1998.Intervention development
Individualised audit and feedback interventions
Monthly prescribing volume was determined by the
number of antibiotic items (BNF section 5.1) prescribed
in the General Dental Service and subsequently dis-
pensed each month. The monthly number of claims was
determined as the number of ordinary list claims for
treatment recorded in MIDAS each month (i.e., claims
made for NHS treatment carried out for patients regis-
tered under a dentist’s standard list number at a given
location). Claims made on other lists, e.g., emergency,
trainer, and assistant were excluded. After the six-month
intervention was delivered, the status of some ordinary
lists in MIDAS was reclassified as public dental service
and these will be included thereafter. For each individual
GDP, the prescribing rate was calculated as the monthly
number of items dispensed divided by the mean monthly
number of claims (multiplied by 100). The initial feedback
contained retrospective prescribing rates taken from the
previous 14 months (November 2011 to December 2012).
Monthly prescribing rates for health boards were simi-
larly calculated based on total antibiotic items pre-
scribed and total number of treatment claims within
each health board.
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The sections on bacterial infections, in the published
SDCEP clinical guidance on ‘Drug Prescribing for
Dentistry’, were coded for the presence/absence of BCTs
using the 2012 BCT taxonomy [13,14]. Two BCTs were
identified: instruction on how to perform the behaviour;
and provide information about health consequences of
performing the behaviour. These BCTs were therefore
selected for inclusion within a text-based intervention.
The SDCEP guidance included behavioural instruction
relating to pre-decision processes, i.e., whether or not it
is appropriate to prescribe antibiotics; and post-decision
processes, i.e., ways to optimise antibiotic prescribing once
the decision to prescribe had been made. We chose to in-
clude only the BCTs that focussed on the pre-decision
processes. Where possible, the exact wording from the
SDCEP guidance document was used. A number of po-
tential BCTs coded in the guidance had to be excluded
from the final text-based intervention due to insufficient
specification of behaviour. For example, the behaviour
‘take care’ within ‘take care when prescribing these antibi-
otics to vulnerable groups’ was not explicit enough to be
included as ‘instruction on how to perform the behaviour’.
The wording of text-based intervention used in the trial is:
‘Prescribing courses of antibiotic treatment can
encourage the development of antimicrobial
resistance and therefore must be kept to a minimum’.
‘As a first step in the treatment of bacterial infections,
use local measures. For example, drain pus if present
in dental abscesses by extraction of the tooth or
through root canals, and attempt to drain any soft-
tissue pus by incision’.
‘This should be the first step even if patients request
antibiotics and even when time is short’.
‘Antibiotics are appropriate for oral infections where
there is evidence of spreading infection, systemic
involvement or persistent swelling despite local
treatment’.
‘Use antibiotics in conjunction with, and not as an
alternative to, local measures’.
The development of the text-based intervention is re-
ported in more detail in Additional file 1.
Study population and eligibility
Practice addresses and the names of all GDPs working
in NHS General Dental Practices across the 14 Scottish
Health Boards were identified from the April 2013 PSD
GDP list.Dental practice inclusion criterion
NHS General Dental Practices across the 14 Health
Boards in Scotland.
Dental practice exclusion criteria
Practices in mainland Health Boards in which any GDPs
were salaried (Salaried GDPs are used as a proxy to
identify community and emergency dental services). Pre-
dominantly due to geography, the majority of dental ser-
vices in the Island Health Boards are provided by the
NHS salaried service. For this reason, practices with sal-
aried GDPs in the Island Boards are not excluded).
General Dental Practices where no ordinary list claims
were made in more than 6 months out of the most re-
cently available 12 months of MIDAS data at the time of
the baseline intervention (January to December 2012).
GDPs inclusion criteria
For the baseline intervention, GDPs listed by PSD as
currently practicing in April 2013.
For the six-month intervention, GDPs listed by PSD as
currently practicing in October 2013.
For the nine-month intervention, GDPs listed by PSD
as currently practicing in January 2014.
GDPs exclusion criterion
GDPs with no name recorded in the PSD list.
Randomisation and allocation
All eligible practices (n = 795) were simultaneously rando-
mised by AE at the beginning of the trial before any base-
line feedback data were issued. The allocation schedule for
random assignment was computer generated. Practices
were ordered randomly, with the first 632 practices being
allocated to an A&F intervention and the remaining prac-
tices being allocated to the control group. Each of the 632
intervention practices was allocated to one of the eight
subgroups (see Figure 1) with an even allocation so that 79
practices were randomised to each subgroup. Randomisa-
tion was also be stratified by single-handed/multi-handed
practices.
Initial and follow-up procedures
All GDPs working in the 632 practices allocated to an
intervention group received feedback (i.e., feedback on
antibiotic prescribing ± a comparator, ± a text based
intervention) at baseline (May 2013) and updated feed-
back at six months (Nov 2013) (Figure 1). At nine
months (February 2014), a further round of feedback will
be delivered to GDPs in 50% of practices allocated to an
intervention group (Figure 1). All intervention documents
will be in paper form and delivered by post (Figure 2).
These will be accompanied by a personalised cover letter
providing information about the study and contact details
Figure 2 Example feedback intervention document (anonymised with pseudonym).
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or requests for further information (Additional file 2).
The feedback at six months is in the same format as
the baseline feedback but contains a further six months
of prescribing rate data in addition to the 14 months of
data fed back at baseline. The nine-month feedback will
again be of a similar format. Additional PRISMS and
MIDAS data were obtained from ISD to include data up
to June 2013 for the six-month feedback and will be ob-
tained to September 2013 for the nine-month feedback.
The linked data relating to the 795 included practices
from these updated datasets will also be linked to the list
of eligible GDPs published by PSD (in October 2013 for
the six-month update, in January 2014 for the nine-
month update). Updated feedback sheets will be sent to
GDPs at practices randomised to the intervention group.
It is recognised that some GDPs and practices may be
lost to follow-up (e.g., if a practice closes or a GDP stops
practising in Scotland).
Outcomes
All outcomes pertain to cluster level (i.e., dental practices).
The primary outcome is the total number of antibiotic
items (from Section 5.1 of the British National Formulary
[15]) dispensed per 100 claims over the 12 months from
May 2013 to April 2014.
The secondary outcomes are:
1. Total number of Amoxicillin 3 g items dispensed per
100 claims over the 12 months from May 2013 to
April 2014 [16].
2. Total number of ‘second-line’ antibiotic items
(Clindamycin, Co-amoxiclav, Clarithromycin) [1]
dispensed per 100 claims over the 12 months from
May 2013 to April 2014.
3. Total defined daily doses of antibiotics [17] (from
Section 5.1 of the British National Formulary [15])
dispensed per 100 claims over the 12 months from
May 2013 to April 2014.
4. Total defined daily doses of Amoxicillin 3 g
dispensed per 100 claims over the 12 months from
May 2013 to April 2014.
5. Total defined daily doses of ‘second-line’ antibiotics
(Clindamycin, Co-amoxiclav, Clarithromycin) [1]
dispensed per 100 claims over the 12 months from
May 2013 to April 2014.
Data collection and processing
Schedule of data collection
MIDAS and PRISMS data are updated routinely by ISD
on a monthly basis with a time lag of between two and
three months. Updates of data will be received by the
TRiaDS Office every month throughout the duration of
the trial. Data covering the period up to 31 December2012 was received in March 2013 and used for the inter-
vention at baseline. Data up to 30 June 2013 was re-
ceived in September 2013 and used for the six-month
intervention (feedback was disseminated on 1 November
2013). Similarly, data up to 30 September 2013 will be
used for the nine-month intervention (feedback will be
disseminated on 1 February 2014).
Analysis plans
Statistical analysis
Outcomes will be aggregated and analysed at the prac-
tice level. The analysis will estimate the effect of each
intervention compared with current practice and will
also estimate the differential effect between interventions
(i.e., inclusion of a text-based intervention, frequency of
feedback and inclusion of a comparator). We will perform
main effects analyses of covariance on the 12-month pre-
scribing rate, adjusting for the pre-intervention yearly pre-
scribing rate, practice size (single-handed/multi-handed),
and the annual number of treatment claims submitted by
the practice. The model fitting strategy will test the prac-
tice size variable (design), then the pre-intervention pre-
scribing rate (covariate), and lastly a categorical variable
(intervention) will be included to correspond with the
main effects of the different interventions. The same ap-
proach will be used for all prescribing behaviours under
investigation.
We will investigate whether larger effects of the inter-
ventions are observed for practices reporting higher
pre-intervention levels of prescribing (defined as upper
quartile practices). Additionally, to test for a reduction
in the spread of prescribing levels, we will apply
Levene’s test for equality of variances between the pre-
intervention and intervention phases.
Timing and frequency of analysis
A single principle analysis is anticipated at 12 months
post baseline intervention (i.e., covering up to 30 April
2014). The data will be available in July 2014 and will be
used to measure all outcomes.
Sample size
The sample size calculation is based on aggregated prac-
tice level antibiotic prescribing. There will be 795 prac-
tices participating in the trial, of which 632 practices will
be randomised to the intervention group. Each of the
eight sub-level experimental units in the intervention
group will have 79 practices. This is the required sample
size to achieve 80% power (with two-sided alpha of 2.5%
allowing for multiple comparisons) to detect a 10% dif-
ference in overall antibiotic prescribing between inter-
vention groups. This applies to the comparison between
A&F only (n = 316) and A&F with a text-based inter-
vention (n = 316), the comparison between feedback at
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only and the comparison between those with and with-
out a Health Board comparator. The sample size has been
reduced using the correction described by Borm et al. for
trials with correlated data [18]. The comparison between
the control group (n = 163) and the intervention group
(n = 632) will have 80% power to detect a 12% decrease
in overall antibiotic prescribing.
The sample size calculation is based on prescribing ac-
tivity recorded in PRISMS for the 1,799 dentist lists in
Scotland known to be prescribing throughout the year
ending June 2010. The mean number of antibiotic items
prescribed per list was 141.1 with an SD of 140.9. The
correlation with the year ending June 2009 is 0.91.
Process evaluation
The 2008 Medical Research Council guidance for de-
veloping complex interventions [19] proposes the use
of evidence and theory to develop an understanding of
the likely processes of change. In order to facilitate un-
derstanding of the processes associated with antibiotic
prescribing in dentistry, we will conduct a concurrent
theoretically informed process evaluation using the
Theoretical Domains Framework (TDF) [20,21] from
health psychology and the Consolidated Framework for
Implementation Research (CFIR) [22]. The TDF is built
from 33 behavioural theories, and proposes that deter-
minants of healthcare professionals’ behaviour cluster
into 14 ‘domains’ (e.g., beliefs about consequences, so-
cial influences, professional role and identity) [21]. It
allows for consideration of a comprehensive range of
potential influences on health professional behaviour
and evidence suggests that TDF-based interviews may
prompt respondents to identify barriers that they would
not otherwise report [23]. In this study, the behaviour
of interest is managing dental patients with bacterial
infections using local measures rather than prescribing
antibiotics. The CFIR consists of common constructs
from published implementation theories and offers an
over-arching typology to promote implementation the-
ory development and verification to understand the
mechanism about what works, where, and why across
various contexts [22].
The process evaluation will involve semi-structured
telephone interviews, with up to 30 GDPs working
within eligible dental practices (i.e., practices allocated to
an A&F intervention group or allocated to the control
group). The aims of the process evaluation are to: iden-
tify barriers and enablers to evidence-based antibiotic
prescribing behaviour by GDPs (i.e., barriers and en-
ablers to managing patients with bacterial infections
using local measures rather than prescribing antibiotics);
and explore GDPs’ experiences of and response to the
individualised A&F interventions.Sampling and recruitment
Potential participants will be identified from the linked
MIDAS and PRISMS data. All GDPs included in the
RAPiD trial (control and intervention groups) will be
categorised into three groups (low, medium, and high)
according to their antibiotic prescribing level during the
period covered by the baseline intervention. Low pre-
scribers are those whose prescribing rate was in the
lower quartile in every month and high prescribers are
those whose prescribing rate was in the upper quartile
in every month. The remaining GDPs will be categorised
as medium prescribers. Three hundred potential partici-
pants (100 low prescribers, 100 medium, and 100 high)
will be sampled using implicit stratification ensuring
representativeness based on the following baseline fac-
tors: Health Board; practice prescribing profile (e.g., all
GDPs in the practice are high/medium/low prescribers
or a mixture of high/medium/low prescribers); practice
size (i.e., single/multi-handed).
A purposive sample of between 15 and 30 GDPs will
be interviewed (e.g., up to 12 GDPs from each of the two
main intervention groups plus six from the control
group). Recruitment will commence after the six-month
feedback in the RAPiD trial (January 2014) and will con-
tinue until 30 GDPs have been interviewed, or until data
saturation occurs across the theoretical domains (i.e., no
new beliefs are being introduced within the 14 TDF do-
mains) [24]. Throughout recruitment, diversity variables
will be tracked in order to inform ongoing sampling of
potential participants and maximise representativeness
in terms of: individual prescribing level (low/medium/
high antibiotic prescribers); practice prescribing profile;
Health Board; practice size; and rurality and deprivation.
Rurality will be measured by the urban/rural classifica-
tion [25] and deprivation by the Scottish Index of Mul-
tiple Deprivation (SIMD) category [26], with both
measures based on the practice postcode.
A letter of invitation to take part in the interview study
(with an option to opt out of being contacted further)
will be sent initially to 100 of the 300 potential partici-
pants representative on the diversity variables of interest
(e.g., prescribing level, health board) and on interven-
tion/control allocation. GDPs who contacted the TRiaDS
Office after receiving their intervention materials will
also be included in this initial batch of invitations. As an
incentive, GDPs who take part in the interview study
will be eligible to claim a payment of £40. The response
rate from the initial mailing will determine the need to
send letters of invitation to the remaining 200 GDPs in
the stratified sample. That is to say, if recruitment from
the initial 100 letters fails to result in 30 interviews, a
further 100 letters will be sent. The process will be re-
peated a third time if necessary in order to achieve a
sample of 30 GDPs.
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not opt out will be contacted by a member of the re-
search team, by telephone, to discuss the study and to
ascertain their willingness to take part. A mutually con-
venient time for a telephone interview will be arranged
with those GDPs expressing an interest in taking part.
No further contact will be made with dentists who do
not wish to be interviewed. Informed verbal (recorded)
consent will be obtained from all participants prior to
interview.
Data collection and analysis
A semi-structured topic guide has been developed based
on the TDF and CFIR to address the aims of the process
evaluation (Additional file 3). Telephone interviews will
last approximately 30 minutes and, with the participants’
permission, will be audio-recorded and transcribed ver-
batim. Telephone interviews are considered more appro-
priate than face-to-face interviews for this study. This
decision relates both to attempts to minimise potential
burden for participants and to the efficient use of re-
sources (i.e., time, cost, effort) for generating data on
this national sample.
The transcribed interviews will be content analysed in
NVivo using the TDF and CFIR as coding frameworks
[22,27]. Data will be analysed throughout recruitment on
an on-going basis until a sample size of 30 is achieved,
or the point of saturation (where no new responses
emerge) is reached [24]. In addition to identifying spe-
cific beliefs relating to prescribing behaviour, the ana-
lyses will aim to determine which domains could be
potential intervention targets [27]. There will be re-
search team discussion throughout analysis process to
raise multiple perspectives, and decision will be made
through a process of deliberation and consensus.
Ethical considerations and authorisations
All members of the RAPiD trial study team have under-
gone training in Good Clinical Practice (GCP). GCP is
an international ethical and scientific quality standard
for designing, conducting, recording, and reporting stud-
ies that involve human participants.
In September 2011, a harmonised edition of the UK
Governance Arrangements for Research Ethics Commit-
tees (GAfREC) came into effect and research involving
NHS staff as participants by virtue of their professional role
was excluded from the normal remit of NHS Research
Ethics Committees. The East of Scotland Research Ethics
Service considered the RAPiD trial protocol and con-
firmed that it did not require ethical review or approval by
an NHS REC (Ref: 11/GA/229). In addition, the protocol
was submitted to the NHS Research Scotland Permissions
Coordinating Centre and reviewed by the Tayside Medical
Science Centre (TASC) Research and Development (R&D)office. They classified the RAPiD trial as service develop-
ment/audit and confirmed that it did not require R&D
registration, formal review, or approval. Confirmation has
been received from all 14 Scottish Health Boards that they
have been notified about the trial and have added it to
their Audit and Clinical Governance records. The RAPiD
trial’s International Standard Randomised Controlled Trial
Number (ISRCTN) registration is ISRCTN 49204710.
Trial status
To date (December 2013), baseline and six-month feed-
back interventions have been delivered.
Discussion
The RAPiD trial has been designed to test the effective-
ness of individualised A&F strategies for the implementa-
tion of evidence-based guidance on antibiotic prescribing
in real world dental practice. The trial is being conducted
as part of the TRiaDS programme of multi-disciplinary
implementation research embedded within the SDCEP
guidance development process [12]. TRiaDS and SDCEP
have a national, education, and service remit to support
the development and implementation of national clinical
guidance addressing quality improvement and patient
safety priorities for dental healthcare in Scotland. The Pro-
grammes’ collaborative links with dental healthcare policy
makers and providers have ensured the research question
addressed meets the needs of the service and have in-
creased the likelihood of the most effective intervention
being adopted as part of routine service delivery [12].
The study is innovative in its use of routinely collected
electronic healthcare data across all stages of the trial
design. In particular, administrative datasets held by ISD
(MIDAS and PRISMS) are linked to: identify the study
population; apply eligibility criteria; carry out stratified
randomisation; generate individualised feedback for the
trial intervention; and analyse trial outcomes. Methodo-
logical strengths of this design include: minimisation of
assessment reactivity (e.g., non-contact recruitment of
trial participants, no contact (postal) delivery of the trial
intervention; and no self-report measures); no opportun-
ity for researchers to influence the antibiotic prescribing
rates presented in the feedback [28]. These features re-
duce the potential for pre- and post-randomisation
sources of bias associated with recruitment, baseline as-
sessment activities, exposure to study conditions, and to
assessment at follow-up [28]. Another methodological
strength of the RAPiD trial is that it operationalises pub-
lished recommendations for the design of A&F inter-
vention studies [10]. Specifically, RAPiD adopts ‘best
practices’ for A&F components (e.g., data are individua-
lised, based on recent performance and new data are
presented over time), investigates further optimisation
strategies in conjunction with a process evaluation and
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based intervention [10].
The use of administrative datasets presents limitations
as well as strengths. For example, PRISMS collects dis-
pensing rather than prescribing data and MIDAS is a re-
pository for remuneration data rather than treatment
provided. Claims for payment for dental treatment are
submitted to MIDAS at the end of a course of treatment.
In some instances, a course of treatment may be deliv-
ered over a number of weeks, while an antibiotic may be
prescribed and dispensed at any time during this period.
Thus, only a proxy measure of the rate of antibiotic pre-
scribing can be obtained from these datasets.
The SDCEP guidance for Drug Prescribing in Dentis-
try states that it is appropriate to prescribe antibiotics ‘if
local measures prove ineffective or if there is evidence of
cellulitis, spreading infection or systemic involvement’
[1]. However, a limitation of this study is that it is not
possible to determine, from routine data, whether or not
antibiotics have been prescribed appropriately. Another
limitation relates to the three-month time lag between
data being collected by ISD and being made available on
PRISMS and MIDAS.
Evidence suggests that greater effectiveness is shown
with increased frequency of feedback [29]. In the RAPiD
trial we tested two feedback frequencies. However, in the
intervention group with feedback delivered more fre-
quently (zero, six, and nine months) it was not appropri-
ate to deliver the A&F strategies at three months after
baseline, because the graphical feedback would not have
included any post-baseline data.
In summary, the partial factorial cluster trial design
and the theory-based qualitative process evaluation will
provide a robust evaluation of A&F in dentistry in
Scotland and will help elucidate the mechanisms by
which this approach works with a view to maximising
applicability to other settings.Additional files
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